Global Influenza Vaccines Market Research Report 2022(Status and Outlook)

June 2022 | 130 pages | ID: G10819D22FFDEN
Bosson Research

Abstracts

Report Overview

The Global Influenza Vaccines Market Size was estimated at USD 3333.16 million in 2021 and is projected to reach USD 4611.55 million by 2028, exhibiting a CAGR of 4.75% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Influenza Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Vaccines market in any manner.

Global Influenza Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• AstraZeneca
• CSL
• GlaxoSmithKline
• Sanofi
• Altimmune
• BionVax
• FluGen
• FOLIA BIOTECH
• Genentech
• Green Cross
• Medicago
• Moderna Therapeutics
• Novavax
• Shijiazhuang Yiling Pharmaceutical
• SK Chemicals
• UNM Pharma
• Vaccitech
• Vaxart
• Vaxine Pty
• Visterra

Market Segmentation (by Type)

• Trivalent Flu Vaccines
• Quadrivalent Flu Vaccines

Market Segmentation (by Application)

• Adults
• Pediatrics

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Influenza Vaccines Market
• Overview of the regional outlook of the Influenza Vaccines Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Influenza Vaccines
1.2 Key Market Segments
  1.2.1 Influenza Vaccines Segment by Type
  1.2.2 Influenza Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 INFLUENZA VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Influenza Vaccines Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Influenza Vaccines Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 INFLUENZA VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Global Influenza Vaccines Sales by Manufacturers (2017-2022)
3.2 Global Influenza Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.3 Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Vaccines Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Influenza Vaccines Sales Sites, Area Served, Product Type
3.6 Influenza Vaccines Market Competitive Situation and Trends
  3.6.1 Influenza Vaccines Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Influenza Vaccines Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 INFLUENZA VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Influenza Vaccines Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 INFLUENZA VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Vaccines Sales Market Share by Type (2017-2022)
6.3 Global Influenza Vaccines Market Size Market Share by Type (2017-2022)
6.4 Global Influenza Vaccines Price by Type (2017-2022)

7 INFLUENZA VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Vaccines Market Sales by Application (2017-2022)
7.3 Global Influenza Vaccines Market Size (M USD) by Application (2017-2022)
7.4 Global Influenza Vaccines Sales Growth Rate by Application (2017-2022)

8 INFLUENZA VACCINES MARKET SEGMENTATION BY REGION

8.1 Global Influenza Vaccines Sales by Region
  8.1.1 Global Influenza Vaccines Sales by Region
  8.1.2 Global Influenza Vaccines Sales Market Share by Region
8.2 North America
  8.2.1 North America Influenza Vaccines Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Influenza Vaccines Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Influenza Vaccines Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Influenza Vaccines Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Influenza Vaccines Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 AstraZeneca
  9.1.1 AstraZeneca Influenza Vaccines Basic Information
  9.1.2 AstraZeneca Influenza Vaccines Product Overview
  9.1.3 AstraZeneca Influenza Vaccines Product Market Performance
  9.1.4 AstraZeneca Business Overview
  9.1.5 AstraZeneca Influenza Vaccines SWOT Analysis
  9.1.6 AstraZeneca Recent Developments
9.2 CSL
  9.2.1 CSL Influenza Vaccines Basic Information
  9.2.2 CSL Influenza Vaccines Product Overview
  9.2.3 CSL Influenza Vaccines Product Market Performance
  9.2.4 CSL Business Overview
  9.2.5 CSL Influenza Vaccines SWOT Analysis
  9.2.6 CSL Recent Developments
9.3 GlaxoSmithKline
  9.3.1 GlaxoSmithKline Influenza Vaccines Basic Information
  9.3.2 GlaxoSmithKline Influenza Vaccines Product Overview
  9.3.3 GlaxoSmithKline Influenza Vaccines Product Market Performance
  9.3.4 GlaxoSmithKline Business Overview
  9.3.5 GlaxoSmithKline Influenza Vaccines SWOT Analysis
  9.3.6 GlaxoSmithKline Recent Developments
9.4 Sanofi
  9.4.1 Sanofi Influenza Vaccines Basic Information
  9.4.2 Sanofi Influenza Vaccines Product Overview
  9.4.3 Sanofi Influenza Vaccines Product Market Performance
  9.4.4 Sanofi Business Overview
  9.4.5 Sanofi Influenza Vaccines SWOT Analysis
  9.4.6 Sanofi Recent Developments
9.5 Altimmune
  9.5.1 Altimmune Influenza Vaccines Basic Information
  9.5.2 Altimmune Influenza Vaccines Product Overview
  9.5.3 Altimmune Influenza Vaccines Product Market Performance
  9.5.4 Altimmune Business Overview
  9.5.5 Altimmune Influenza Vaccines SWOT Analysis
  9.5.6 Altimmune Recent Developments
9.6 BionVax
  9.6.1 BionVax Influenza Vaccines Basic Information
  9.6.2 BionVax Influenza Vaccines Product Overview
  9.6.3 BionVax Influenza Vaccines Product Market Performance
  9.6.4 BionVax Business Overview
  9.6.5 BionVax Recent Developments
9.7 FluGen
  9.7.1 FluGen Influenza Vaccines Basic Information
  9.7.2 FluGen Influenza Vaccines Product Overview
  9.7.3 FluGen Influenza Vaccines Product Market Performance
  9.7.4 FluGen Business Overview
  9.7.5 FluGen Recent Developments
9.8 FOLIA BIOTECH
  9.8.1 FOLIA BIOTECH Influenza Vaccines Basic Information
  9.8.2 FOLIA BIOTECH Influenza Vaccines Product Overview
  9.8.3 FOLIA BIOTECH Influenza Vaccines Product Market Performance
  9.8.4 FOLIA BIOTECH Business Overview
  9.8.5 FOLIA BIOTECH Recent Developments
9.9 Genentech
  9.9.1 Genentech Influenza Vaccines Basic Information
  9.9.2 Genentech Influenza Vaccines Product Overview
  9.9.3 Genentech Influenza Vaccines Product Market Performance
  9.9.4 Genentech Business Overview
  9.9.5 Genentech Recent Developments
9.10 Green Cross
  9.10.1 Green Cross Influenza Vaccines Basic Information
  9.10.2 Green Cross Influenza Vaccines Product Overview
  9.10.3 Green Cross Influenza Vaccines Product Market Performance
  9.10.4 Green Cross Business Overview
  9.10.5 Green Cross Recent Developments
9.11 Medicago
  9.11.1 Medicago Influenza Vaccines Basic Information
  9.11.2 Medicago Influenza Vaccines Product Overview
  9.11.3 Medicago Influenza Vaccines Product Market Performance
  9.11.4 Medicago Business Overview
  9.11.5 Medicago Recent Developments
9.12 Moderna Therapeutics
  9.12.1 Moderna Therapeutics Influenza Vaccines Basic Information
  9.12.2 Moderna Therapeutics Influenza Vaccines Product Overview
  9.12.3 Moderna Therapeutics Influenza Vaccines Product Market Performance
  9.12.4 Moderna Therapeutics Business Overview
  9.12.5 Moderna Therapeutics Recent Developments
9.13 Novavax
  9.13.1 Novavax Influenza Vaccines Basic Information
  9.13.2 Novavax Influenza Vaccines Product Overview
  9.13.3 Novavax Influenza Vaccines Product Market Performance
  9.13.4 Novavax Business Overview
  9.13.5 Novavax Recent Developments
9.14 Shijiazhuang Yiling Pharmaceutical
  9.14.1 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Basic Information
  9.14.2 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Overview
  9.14.3 Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Market Performance
  9.14.4 Shijiazhuang Yiling Pharmaceutical Business Overview
  9.14.5 Shijiazhuang Yiling Pharmaceutical Recent Developments
9.15 SK Chemicals
  9.15.1 SK Chemicals Influenza Vaccines Basic Information
  9.15.2 SK Chemicals Influenza Vaccines Product Overview
  9.15.3 SK Chemicals Influenza Vaccines Product Market Performance
  9.15.4 SK Chemicals Business Overview
  9.15.5 SK Chemicals Recent Developments
9.16 UNM Pharma
  9.16.1 UNM Pharma Influenza Vaccines Basic Information
  9.16.2 UNM Pharma Influenza Vaccines Product Overview
  9.16.3 UNM Pharma Influenza Vaccines Product Market Performance
  9.16.4 UNM Pharma Business Overview
  9.16.5 UNM Pharma Recent Developments
9.17 Vaccitech
  9.17.1 Vaccitech Influenza Vaccines Basic Information
  9.17.2 Vaccitech Influenza Vaccines Product Overview
  9.17.3 Vaccitech Influenza Vaccines Product Market Performance
  9.17.4 Vaccitech Business Overview
  9.17.5 Vaccitech Recent Developments
9.18 Vaxart
  9.18.1 Vaxart Influenza Vaccines Basic Information
  9.18.2 Vaxart Influenza Vaccines Product Overview
  9.18.3 Vaxart Influenza Vaccines Product Market Performance
  9.18.4 Vaxart Business Overview
  9.18.5 Vaxart Recent Developments
9.19 Vaxine Pty
  9.19.1 Vaxine Pty Influenza Vaccines Basic Information
  9.19.2 Vaxine Pty Influenza Vaccines Product Overview
  9.19.3 Vaxine Pty Influenza Vaccines Product Market Performance
  9.19.4 Vaxine Pty Business Overview
  9.19.5 Vaxine Pty Recent Developments
9.20 Visterra
  9.20.1 Visterra Influenza Vaccines Basic Information
  9.20.2 Visterra Influenza Vaccines Product Overview
  9.20.3 Visterra Influenza Vaccines Product Market Performance
  9.20.4 Visterra Business Overview
  9.20.5 Visterra Recent Developments

10 INFLUENZA VACCINES MARKET FORECAST BY REGION

10.1 Global Influenza Vaccines Market Size Forecast
10.2 Global Influenza Vaccines Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Influenza Vaccines Market Size Forecast by Country
  10.2.3 Asia Pacific Influenza Vaccines Market Size Forecast by Region
  10.2.4 South America Influenza Vaccines Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Influenza Vaccines by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Influenza Vaccines Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Influenza Vaccines by Type (2022-2028)
  11.1.2 Global Influenza Vaccines Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Influenza Vaccines by Type (2022-2028)
11.2 Global Influenza Vaccines Market Forecast by Application (2022-2028)
  11.2.1 Global Influenza Vaccines Sales (K Units) Forecast by Application
  11.2.2 Global Influenza Vaccines Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Vaccines Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Influenza Vaccines Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Influenza Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Influenza Vaccines Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Influenza Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccines as of 2021)
Table 10. Global Market Influenza Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Influenza Vaccines Sales Sites and Area Served
Table 12. Manufacturers Influenza Vaccines Product Type
Table 13. Global Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Vaccines
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Vaccines Market Challenges
Table 22. Market Restraints
Table 23. Global Influenza Vaccines Sales by Type (K Units)
Table 24. Global Influenza Vaccines Market Size by Type (M USD)
Table 25. Global Influenza Vaccines Sales (K Units) by Type (2017-2022)
Table 26. Global Influenza Vaccines Sales Market Share by Type (2017-2022)
Table 27. Global Influenza Vaccines Market Size (M USD) by Type (2017-2022)
Table 28. Global Influenza Vaccines Market Size Share by Type (2017-2022)
Table 29. Global Influenza Vaccines Price (USD/Unit) by Type (2017-2022)
Table 30. Global Influenza Vaccines Sales (K Units) by Application
Table 31. Global Influenza Vaccines Market Size by Application
Table 32. Global Influenza Vaccines Sales by Application (2017-2022) & (K Units)
Table 33. Global Influenza Vaccines Sales Market Share by Application (2017-2022)
Table 34. Global Influenza Vaccines Sales by Application (2017-2022) & (M USD)
Table 35. Global Influenza Vaccines Market Share by Application (2017-2022)
Table 36. Global Influenza Vaccines Sales Growth Rate by Application (2017-2022)
Table 37. Global Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 38. Global Influenza Vaccines Sales Market Share by Region (2017-2022)
Table 39. North America Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 40. Europe Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 42. South America Influenza Vaccines Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Influenza Vaccines Sales by Region (2017-2022) & (K Units)
Table 44. AstraZeneca Influenza Vaccines Basic Information
Table 45. AstraZeneca Influenza Vaccines Product Overview
Table 46. AstraZeneca Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca Influenza Vaccines SWOT Analysis
Table 49. AstraZeneca Recent Developments
Table 50. CSL Influenza Vaccines Basic Information
Table 51. CSL Influenza Vaccines Product Overview
Table 52. CSL Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. CSL Business Overview
Table 54. CSL Influenza Vaccines SWOT Analysis
Table 55. CSL Recent Developments
Table 56. GlaxoSmithKline Influenza Vaccines Basic Information
Table 57. GlaxoSmithKline Influenza Vaccines Product Overview
Table 58. GlaxoSmithKline Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. GlaxoSmithKline Business Overview
Table 60. GlaxoSmithKline Influenza Vaccines SWOT Analysis
Table 61. GlaxoSmithKline Recent Developments
Table 62. Sanofi Influenza Vaccines Basic Information
Table 63. Sanofi Influenza Vaccines Product Overview
Table 64. Sanofi Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Sanofi Business Overview
Table 66. Sanofi Influenza Vaccines SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Altimmune Influenza Vaccines Basic Information
Table 69. Altimmune Influenza Vaccines Product Overview
Table 70. Altimmune Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Altimmune Business Overview
Table 72. Altimmune Influenza Vaccines SWOT Analysis
Table 73. Altimmune Recent Developments
Table 74. BionVax Influenza Vaccines Basic Information
Table 75. BionVax Influenza Vaccines Product Overview
Table 76. BionVax Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. BionVax Business Overview
Table 78. BionVax Recent Developments
Table 79. FluGen Influenza Vaccines Basic Information
Table 80. FluGen Influenza Vaccines Product Overview
Table 81. FluGen Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. FluGen Business Overview
Table 83. FluGen Recent Developments
Table 84. FOLIA BIOTECH Influenza Vaccines Basic Information
Table 85. FOLIA BIOTECH Influenza Vaccines Product Overview
Table 86. FOLIA BIOTECH Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. FOLIA BIOTECH Business Overview
Table 88. FOLIA BIOTECH Recent Developments
Table 89. Genentech Influenza Vaccines Basic Information
Table 90. Genentech Influenza Vaccines Product Overview
Table 91. Genentech Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Genentech Business Overview
Table 93. Genentech Recent Developments
Table 94. Green Cross Influenza Vaccines Basic Information
Table 95. Green Cross Influenza Vaccines Product Overview
Table 96. Green Cross Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Green Cross Business Overview
Table 98. Green Cross Recent Developments
Table 99. Medicago Influenza Vaccines Basic Information
Table 100. Medicago Influenza Vaccines Product Overview
Table 101. Medicago Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Medicago Business Overview
Table 103. Medicago Recent Developments
Table 104. Moderna Therapeutics Influenza Vaccines Basic Information
Table 105. Moderna Therapeutics Influenza Vaccines Product Overview
Table 106. Moderna Therapeutics Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Moderna Therapeutics Business Overview
Table 108. Moderna Therapeutics Recent Developments
Table 109. Novavax Influenza Vaccines Basic Information
Table 110. Novavax Influenza Vaccines Product Overview
Table 111. Novavax Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Novavax Business Overview
Table 113. Novavax Recent Developments
Table 114. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Basic Information
Table 115. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Product Overview
Table 116. Shijiazhuang Yiling Pharmaceutical Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Shijiazhuang Yiling Pharmaceutical Business Overview
Table 118. Shijiazhuang Yiling Pharmaceutical Recent Developments
Table 119. SK Chemicals Influenza Vaccines Basic Information
Table 120. SK Chemicals Influenza Vaccines Product Overview
Table 121. SK Chemicals Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. SK Chemicals Business Overview
Table 123. SK Chemicals Recent Developments
Table 124. UNM Pharma Influenza Vaccines Basic Information
Table 125. UNM Pharma Influenza Vaccines Product Overview
Table 126. UNM Pharma Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. UNM Pharma Business Overview
Table 128. UNM Pharma Recent Developments
Table 129. Vaccitech Influenza Vaccines Basic Information
Table 130. Vaccitech Influenza Vaccines Product Overview
Table 131. Vaccitech Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Vaccitech Business Overview
Table 133. Vaccitech Recent Developments
Table 134. Vaxart Influenza Vaccines Basic Information
Table 135. Vaxart Influenza Vaccines Product Overview
Table 136. Vaxart Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Vaxart Business Overview
Table 138. Vaxart Recent Developments
Table 139. Vaxine Pty Influenza Vaccines Basic Information
Table 140. Vaxine Pty Influenza Vaccines Product Overview
Table 141. Vaxine Pty Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Vaxine Pty Business Overview
Table 143. Vaxine Pty Recent Developments
Table 144. Visterra Influenza Vaccines Basic Information
Table 145. Visterra Influenza Vaccines Product Overview
Table 146. Visterra Influenza Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Visterra Business Overview
Table 148. Visterra Recent Developments
Table 149. Global Influenza Vaccines Sales Forecast by Region (K Units)
Table 150. Global Influenza Vaccines Market Size Forecast by Region (M USD)
Table 151. North America Influenza Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 152. North America Influenza Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 153. Europe Influenza Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 154. Europe Influenza Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 155. Asia Pacific Influenza Vaccines Sales Forecast by Region (2022-2028) & (K Units)
Table 156. Asia Pacific Influenza Vaccines Market Size Forecast by Region (2022-2028) & (M USD)
Table 157. South America Influenza Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 158. South America Influenza Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 159. Middle East and Africa Influenza Vaccines Consumption Forecast by Country (2022-2028) & (Units)
Table 160. Middle East and Africa Influenza Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 161. Global Influenza Vaccines Sales Forecast by Type (2022-2028) & (K Units)
Table 162. Global Influenza Vaccines Market Size Forecast by Type (2022-2028) & (M USD)
Table 163. Global Influenza Vaccines Price Forecast by Type (2022-2028) & (USD/Unit)
Table 164. Global Influenza Vaccines Sales (K Units) Forecast by Application (2022-2028)
Table 165. Global Influenza Vaccines Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Vaccines Market Size (M USD), 2017-2028
Figure 5. Global Influenza Vaccines Market Size (M USD) (2017-2028)
Figure 6. Global Influenza Vaccines Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Vaccines Market Size (M USD) by Country (M USD)
Figure 11. Influenza Vaccines Sales Share by Manufacturers in 2020
Figure 12. Global Influenza Vaccines Revenue Share by Manufacturers in 2020
Figure 13. Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Influenza Vaccines Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Vaccines Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Vaccines Market Share by Type
Figure 18. Sales Market Share of Influenza Vaccines by Type (2017-2022)
Figure 19. Sales Market Share of Influenza Vaccines by Type in 2021
Figure 20. Market Size Share of Influenza Vaccines by Type (2017-2022)
Figure 21. Market Size Market Share of Influenza Vaccines by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Vaccines Market Share by Application
Figure 24. Global Influenza Vaccines Sales Market Share by Application (2017-2022)
Figure 25. Global Influenza Vaccines Sales Market Share by Application in 2021
Figure 26. Global Influenza Vaccines Market Share by Application (2017-2022)
Figure 27. Global Influenza Vaccines Market Share by Application in 2020
Figure 28. Global Influenza Vaccines Sales Growth Rate by Application (2017-2022)
Figure 29. Global Influenza Vaccines Sales Market Share by Region (2017-2022)
Figure 30. North America Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Influenza Vaccines Sales Market Share by Country in 2020
Figure 32. U.S. Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Influenza Vaccines Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Influenza Vaccines Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Influenza Vaccines Sales Market Share by Country in 2020
Figure 37. Germany Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Influenza Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Influenza Vaccines Sales Market Share by Region in 2020
Figure 44. China Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Influenza Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Influenza Vaccines Sales Market Share by Country in 2020
Figure 51. Brazil Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Influenza Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Influenza Vaccines Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Influenza Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Influenza Vaccines Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Influenza Vaccines Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Influenza Vaccines Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Influenza Vaccines Market Share Forecast by Type (2022-2028)
Figure 65. Global Influenza Vaccines Sales Forecast by Application (2022-2028)
Figure 66. Global Influenza Vaccines Market Share Forecast by Application (2022-2028)